Related Experiment Video
Updated: Dec 30, 2025

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
Association between breastfeeding and osteoporotic hip fracture in women: a dose-response meta-analysis
Haixiang Xiao1, Quan Zhou2, Gouqi Niu3
1Department of Orthopedics, Jingjiang People's Hospital, Jingjiang, 214500, China.
Insights
Breastfeeding reduces the risk of osteoporotic hip fractures in women. Longer breastfeeding duration, up to 25 months, shows a greater decrease in fracture incidence, highlighting its bone health benefits.
Area of Science:
- Osteoporosis Research
- Maternal and Child Health
- Geriatric Medicine
Background:
- Breastfeeding is crucial for infant development, supplying approximately 300 mg of calcium daily.
- Women can experience 5-10% bone loss during breastfeeding, increasing osteoporosis risk.
- Osteoporotic hip fractures represent a significant health concern, particularly in older adults.
Purpose of the Study:
- To investigate the association between breastfeeding and the incidence of osteoporotic hip fractures in women.
- To analyze the dose-response relationship between breastfeeding duration and hip fracture risk.
Main Methods:
- A meta-analysis was conducted using studies from PubMed and Embase up to May 2019.
- Study quality was assessed using the Methodological Index for Non-Randomized Studies (MINORS).
- A dose-response meta-analysis employed the generalized least squares for trend estimation method.
Main Results:
- Seven moderate to high-quality studies involving 103,898 subjects were included.
- Breastfeeding was associated with a reduced incidence of osteoporotic hip fractures (RR = 0.64).
- A dose-response relationship was observed: longer breastfeeding duration correlated with lower fracture risk, with significant effects up to 24 months.
Conclusions:
- Extended breastfeeding duration is linked to a decreased incidence of osteoporotic hip fractures.
- The protective effect of breastfeeding on hip fracture risk was significant for durations up to 25 months.
- No significant association was found for breastfeeding durations exceeding 25 months.
Objective:
Approximately 300 mg of calcium a day is provided into infants to maintain the physical development of infants, and 5 to 10% bone loss occurs in women during breastfeeding. Hip fractures are considered the most serious type of osteoporotic fracture. We performed this meta-analysis to investigate the association between breastfeeding and osteoporotic hip fractures.
Material And Methods:
PubMed and Embase were searched until May 1, 2019, for studies evaluating the relationship between breastfeeding and osteoporotic hip fracture in women. The quality of the included studies was evaluated by the methodological index for non-randomized studies (MINORS). For the dose-response meta-analysis, we used the "generalized least squares for trend estimation" method proposed by Greenland and Longnecker to take into account the correlation with the log RR estimates across the duration of breastfeeding.
Results:
Seven studies were moderate or high quality, enrolling a total of 103,898 subjects. The pooled outcomes suggested that breastfeeding can decrease the incidence of osteoporotic hip fracture (RR = 0.64 (95% CI 0.43, 0.95), P = 0.027). Dose-response analysis demonstrated that the incidence of osteoporotic hip fracture decreased with the increase of breastfeeding time. The RR and 95% CI for 3 months, 6 months, 12 months, and 24 months were RR = 0.93, 95% CI 0.88, 0.98; RR = 0.87, 95% CI 0.79, 0.96; RR = 0.79, 95% CI 0.67, 0.92; and RR = 0.76, 95% CI 0.59, 0.98, respectively, whereas no significant relationship was found between them when the duration of breastfeeding time was more than 25 months.
Conclusions:
Our meta-analysis demonstrated that the incidence of osteoporotic hip fracture decreased with the extension of breastfeeding time. However, there is no significant relationship between them when the duration of breastfeeding time was more than 25 months.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Osteoclasts in Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Dose-Response Relationship: Overview